Security
DarioHealth Corp. Common Stock · DRIO
DRIONASDAQCommon stockCurrentCIK 1533998Updated Nov 14, 2026
Name history
LabStyle Innovations Corp. · through Jul 27, 2016
DRIO price & chart
Loading TradingView…
NASDAQ:DRIO on TradingView ↗About the company
DarioHealth Corp. (NASDAQ: DRIO) is an AI-powered healthcare technology company helping health plans, health systems and employers improve health outcomes while lowering the cost of care. The Company's integrated platform combines connected devices, personalized member engagement, AI-driven insights and provider-backed clinical care to support people living with conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health needs.
In the news
Dario Signs New Agreement with a Major Health Insurer in Arizona Representing Hundreds of Thousands of Lives Through Amwell Partnership ↗
Seeking Alpha
DarioHealth Corp. (DRIO) Q3 2026 Earnings Call Transcript ↗
DarioHealth GAAP EPS of $0.73 beats by $1.68, revenue of $5.31M beats by $0.1M ↗
Here are the major earnings before the open Thursday ↗
SEC disclosures
DarioHealth Corp. files 8-K: Material Event ↗
Recent filings
SCHEDULE 13G/A - filed by Nantahala Capital Management, LLC regarding DarioHealth Corp.
10-Q filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
4 filing
4 filing
Show 5 more recent filings
4 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
10-Q filing
Entry into a Material Definitive Agreement · Other Events
Items 1.01, 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 117,727,000Source | 109,953,000Source | 96,590,000Source | 108,325,000Source | 122,134,000Source | 103,281,000Source | 115,600,000Source | 136,964,000Source | 110,075,000Source | 118,884,000Source | 96,389,000Source | 119,191,000Source |
| Property, Plant and Equipment, NetUSD | 578,000Source | 1,235,000Source | 503,000Source | 610,000Source | 1,334,000Source | 511,000Source | 646,000Source | 1,425,000Source | 549,000Source | 709,000Source | 899,000Source | 788,000Source |
| GoodwillUSD | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 41,640,000Source | 41,640,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 16,405,000Source | 20,343,000Source | 15,000,000Source | 16,878,000Source | 22,346,000Source | 15,468,000Source | 17,600,000Source | 23,646,000Source | 15,931,000Source | 18,762,000Source | 5,404,000Source | 9,916,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 31,907,000Source | 15,547,000Source | 6,634,000Source | 21,954,000Source | 22,938,000Source | 14,977,000Source | 27,854,000Source | 34,367,000Source | 21,803,000Source | 27,764,000Source | 36,797,000Source | 49,357,000Source |
| Inventory, NetUSD | 4,869,000Source | 4,742,000Source | 3,719,000Source | 4,609,000Source | 5,133,000Source | 4,172,000Source | 4,622,000Source | 4,916,000Source | 4,316,000Source | 4,753,000Source | 5,062,000Source | 7,956,000Source |
| Assets, CurrentUSD | 42,185,000Source | 29,528,000Source | 22,126,000Source | 32,170,000Source | 39,340,000Source | 28,734,000Source | 38,562,000Source | 52,509,000Source | 35,067,000Source | 40,529,000Source | 47,330,000Source | 65,524,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 2,812,000Source | 3,428,000Source | 2,604,000Source | 2,833,000Source | 3,679,000Source | 2,079,000Source | 2,687,000Source | 4,370,000Source | 2,361,000Source | 2,336,000Source | 2,024,000Source | 1,630,000Source |
| Operating Lease, Right-of-Use AssetUSD | 746,000Source | 1,306,000Source | 1,029,000Source | 861,000Source | 1,547,000Source | 607,000Source | 955,000Source | 1,813,000Source | 717,000Source | 1,065,000Source | 967,000Source | 1,206,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 4,000Source | 3,000Source | 4,000Source | 4,000Source | 3,000Source | 4,000Source | 4,000Source | 3,000Source | 4,000Source | 4,000Source | 3,000Source | 3,000Source |
| Additional Paid in CapitalUSD | 516,756,000Source | 436,590,000Source | 523,335,000Source | 486,953,000Source | 431,526,000Source | 522,703,000Source | 478,104,000Source | 436,600,000Source | 519,996,000Source | 462,358,000Source | 407,502,000Source | 365,846,000Source |
| Retained Earnings (Accumulated Deficit)USD | -441,826,000Source | -378,082,000Source | -468,251,000Source | -422,971,000Source | -363,474,000Source | -460,327,000Source | -404,409,000Source | -358,570,000Source | -452,078,000Source | -390,343,000Source | -349,361,000Source | -285,850,000Source |
| Stockholders' Equity Attributable to ParentUSD | 74,934,000Source | 58,511,000Source | 55,088,000Source | 63,986,000Source | 68,055,000Source | 62,380,000Source | 73,699,000Source | 78,033,000Source | 67,922,000Source | 72,019,000Source | 58,144,000Source | 79,999,000Source |
| Liabilities and EquityUSD | 117,727,000Source | 109,953,000Source | 96,590,000Source | 108,325,000Source | 122,134,000Source | 103,281,000Source | 115,600,000Source | 136,964,000Source | 110,075,000Source | 118,884,000Source | 96,389,000Source | 119,191,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 9,279,000Source | 18,846,000Source | 9,578,000Source | 9,754,000Source | 17,416,000Source | 9,357,000Source | 19,155,000Source | 17,802,000Source | 9,323,000Source | 16,635,000Source | 12,493,000Source | 19,350,000Source |
| Operating Lease, Liability, CurrentUSD | 442,000Source | 596,000Source | 572,000Source | 510,000Source | 884,000Source | 378,000Source | 490,000Source | 920,000Source | 430,000Source | 504,000Source | 111,000Source | 293,000Source |
| Operating Lease, Liability, NoncurrentUSD | 579,000Source | 1,033,000Source | 777,000Source | 612,000Source | 1,118,000Source | 507,000Source | 653,000Source | 1,053,000Source | 571,000Source | 765,000Source | 885,000Source | 827,000Source |
| Deferred Income Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | 4,174,000Source | 2,430,000Source | 2,485,000Source |
| Other Liabilities, NoncurrentUSD | 74,000Source | 49,000Source | 68,000Source | 81,000Source | 51,000Source | 83,000Source | 91,000Source | 52,000Source | 46,000Source | 25,000Source | 36,000Source | — |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | 2,402,000Source | 1,940,000Source | 2,227,000Source | 2,185,000Source |
| Long-term Debt, Current MaturitiesUSD | — | 8,670,000Source | — | — | 5,191,000Source | — | 10,295,000Source | 3,954,000Source | — | 5,451,000Source | 3,954,000Source | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 30,617,000Source | 20,187,000Source | 31,064,000Source | 30,499,000Source | 23,440,000Source | 30,931,000Source | 18,899,000Source | 24,508,000Source | 30,747,000Source | 23,472,000Source | 24,591,000Source | 18,105,000Source |
| Restricted Cash and Investments, CurrentUSD | — | 663,000Source | — | — | 663,000Source | — | — | 674,000Source | — | — | — | 113,000Source |
| Short-term Investments | — | — | —Source | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -8,249,000Source | -9,227,000Source | -41,714,000Source | -42,747,000Source | -59,427,000Source | -62,193,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | — | — | — | 46,000Source | — | — |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -144,000Source | -130,000Source | -437,000Source | -308,000Source | -2,894,000Source | 1,728,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | -2,001,000Source | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,025,000Source | -6,673,000Source | -25,941,000Source | -38,562,000Source | -30,379,000Source | -47,845,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | 8,796,000Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -826,000Source | -31,000Source | -4,342,000Source | -8,934,000Source | -547,000Source | -573,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 31,000Source | 31,000Source | 142,000Source | 138,000Source | 584,000Source | 442,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 134,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | — | 6,815,000Source | 24,313,000Source | 38,531,000Source | 18,253,000Source | 61,940,000Source |
| Repayments of Long-term DebtUSD | — | — | — | — | — | — | — | — | 31,515,000Source | — | 27,833,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 31,907,000Source | 16,210,000Source | 6,634,000Source | 21,954,000Source | 14,977,000Source | 27,854,000Source | 21,803,000Source | 27,764,000Source | 36,797,000Source | 49,470,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 965,000Source | 937,000Source | 3,493,000Source | 3,927,000Source | 4,031,000Source | 1,876,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 288,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | 25,000Source | -21,000Source | 9,000Source | -68,000Source | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 2,950,000Source | 2,786,000Source | 632,000Source | 2,035,000Source | 1,441,000Source | 2,342,000Source | 9,365,000Source | 15,796,000Source | 19,701,000Source | 16,975,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | 516,000Source | 528,000Source | 4,052,000Source |
| Amortization of Intangible AssetsUSD | — | — | 473,000Source | 2,003,000Source | 468,000Source | 722,000Source | 463,000Source | 1,162,000Source | 2,831,000Source | 6,100,000Source | 4,512,000Source | 4,361,000Source |
| DepreciationUSD | — | — | — | — | — | — | 61,000Source | 94,000Source | 307,000Source | 1,327,000Source | 473,000Source | 356,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -49,000Source | -14,000Source | -118,000Source | -204,000Source | -48,000Source | 42,000Source | -276,000Source | -4,000Source | -210,000Source | 243,000Source |
| General and Administrative ExpenseUSD | — | — | 4,567,000Source | 3,728,000Source | 2,600,000Source | 3,212,000Source | 3,226,000Source | 3,310,000Source | 15,191,000Source | 20,482,000Source | 18,140,000Source | 16,493,000Source |
| GoodwillUSD | — | — | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 57,427,000Source | 41,640,000Source | 41,640,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 10,465,585Source | 12,330,227Source | 7,923,773,000Source | 12,989,626,000Source | 8,248,858,000Source | 9,227,162,000Source | 41,714,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | -13,000Source | 328,000Source | 0Source | 57,000Source | 22,000Source | 105,000Source | -1,852,000Source | 64,000Source | 4,000Source |
| InterestExpenseNonoperatingUSD | — | — | 1,157,000Source | — | 1,123,000Source | — | 1,149,000Source | — | 3,020,000Source | — | — | — |
| Inventory Write-downUSD | — | — | 2,000Source | 103,000Source | 57,000Source | 38,000Source | 0Source | 174,000Source | 320,000Source | 301,000Source | 121,000Source | 88,000Source |
| Investment Income, InterestUSD | — | — | 175,000Source | 226,000Source | 135,000Source | 237,000Source | 160,000Source | 289,000Source | 943,000Source | 1,116,000Source | 1,868,000Source | 506,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,466,000Source | -12,330,000Source | -7,924,000Source | -12,990,000Source | -8,249,000Source | -9,227,000Source | -41,714,000Source | -42,747,000Source | -59,427,000Source | -62,193,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -59,957,000Source |
| Nonoperating Income (Expense)USD | — | — | -982,000Source | -313,000Source | -1,117,000Source | -3,790,000Source | -883,000Source | 204,000Source | -4,954,000Source | 13,145,000Source | -3,174,000Source | -5,379,000Source |
| Operating ExpensesUSD | — | — | 12,499,000Source | 15,907,000Source | 9,671,000Source | 12,164,000Source | 10,509,000Source | 13,291,000Source | 49,320,000Source | 71,011,000Source | 62,173,000Source | 66,465,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 175,000Source | -313,000Source | 6,000Source | -3,790,000Source | 266,000Source | 204,000Source | -1,934,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 38,288,000Source |
| Restricted Cash and Investments, CurrentUSD | — | — | — | 663,000Source | — | — | — | — | — | — | — | 113,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 5,007,000Source | 7,423,000Source | 5,177,000Source | 5,369,000Source | 5,584,000Source | 6,752,000Source | 22,359,000Source | 27,040,000Source | 20,352,000Source | 27,656,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | 37,000Source | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of RevenueUSD | — | — | 1,992,000Source | 3,546,000Source | 1,985,000Source | 2,405,000Source | 2,384,000Source | 2,870,000Source | 9,694,000Source | 13,773,000Source | 14,368,000Source | 18,001,000Source |
| Operating Income (Loss)USD | — | — | -9,484,000Source | -12,030,000Source | -6,479,000Source | -9,200,000Source | -7,309,000Source | -9,409,000Source | -36,655,000Source | -57,744,000Source | -56,189,000Source | -56,810,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 175,000Source | -313,000Source | 6,000Source | -3,790,000Source | 266,000Source | 204,000Source | -1,934,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -10,466,000Source | -12,343,000Source | -7,596,000Source | -12,990,000Source | -8,192,000Source | -9,205,000Source | -41,609,000Source | -44,599,000Source | -59,363,000Source | -62,189,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | -13,000Source | 328,000Source | 0Source | 57,000Source | 22,000Source | 105,000Source | -1,852,000Source | 64,000Source | 4,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,466,000Source | -12,330,000Source | -7,924,000Source | -12,990,000Source | -8,249,000Source | -9,227,000Source | -41,714,000Source | -42,747,000Source | -59,427,000Source | -62,193,000Source |
| Earnings Per Share, BasicUSD per share | — | — | 2.96Source | 4.91Source | 0.85Source | 3.54Source | 1.25Source | 2.87Source | 10.12Source | 0.61Source | 1.93Source | 2.54Source |
| Earnings Per Share, DilutedUSD per share | — | — | 2.96Source | 4.91Source | 0.85Source | 3.54Source | 1.25Source | 2.87Source | 10.12Source | 0.61Source | 1.93Source | 2.54Source |
| Total Revenue | — | — | — | — | — | — | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 3,138,106Source | 2,020,872Source | 9,343,618Source | 2,481,548Source | 6,582,297Source | 2,368,516Source | 3,982,956Source | 49,039,410Source | 28,371,979Source | 23,635,038Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 3,138,106Source | 2,020,872Source | 9,343,618Source | 2,481,548Source | 6,582,297Source | 2,368,516Source | 3,982,956Source | 49,039,410Source | 28,371,979Source | 23,635,038Source |
| Interest Expense (non-operating)USD | — | — | 1,157,000Source | — | 1,123,000Source | — | 1,149,000Source | — | 3,020,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 473,000Source | 2,003,000Source | 468,000Source | 722,000Source | 463,000Source | 1,162,000Source | 2,831,000Source | 6,100,000Source | 4,512,000Source | 4,361,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 105,000Source | 149,000Source | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | — | -49,000Source | -14,000Source | -118,000Source | -204,000Source | -48,000Source | 42,000Source | -276,000Source | -4,000Source | -210,000Source | 243,000Source |
| General and Administrative ExpenseUSD | — | — | 4,567,000Source | 3,728,000Source | 2,600,000Source | 3,212,000Source | 3,226,000Source | 3,310,000Source | 15,191,000Source | 20,482,000Source | 18,140,000Source | 16,493,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 3,015,000Source | 3,877,000Source | 3,192,000Source | 2,964,000Source | 3,200,000Source | 3,882,000Source | 12,665,000Source | 13,267,000Source | 5,984,000Source | 9,655,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | 10,465,585Source | 12,330,227Source | 7,923,773,000Source | 12,989,626,000Source | 8,248,858,000Source | 9,227,162,000Source | 41,714,000Source | — | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -17,708,000Source | -17,863,000Source | -23,477,000Source | -22,902,000Source |
| Interest Expense, DebtUSD | — | — | 1,157,000Source | — | — | — | — | — | — | — | — | 1,876,000Source |
| Investment Income, InterestUSD | — | — | 175,000Source | 226,000Source | 135,000Source | 237,000Source | 160,000Source | 289,000Source | 943,000Source | 1,116,000Source | 1,868,000Source | 506,000Source |
| Marketing and Advertising ExpenseUSD | — | — | 4,604,000Source | 6,733,000Source | 4,971,000Source | 5,231,000Source | 4,898,000Source | 5,873,000Source | 20,338,000Source | 26,350,000Source | 23,785,000Source | 30,323,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -59,957,000Source |
| Nonoperating Income (Expense)USD | — | — | -982,000Source | -313,000Source | -1,117,000Source | -3,790,000Source | -883,000Source | 204,000Source | -4,954,000Source | 13,145,000Source | -3,174,000Source | -5,379,000Source |
| Operating ExpensesUSD | — | — | 12,499,000Source | 15,907,000Source | 9,671,000Source | 12,164,000Source | 10,509,000Source | 13,291,000Source | 49,320,000Source | 71,011,000Source | 62,173,000Source | 66,465,000Source |
| Research and Development ExpenseUSD | — | — | 3,328,000Source | 5,446,000Source | 2,100,000Source | 3,721,000Source | 2,385,000Source | 4,108,000Source | 13,791,000Source | 24,179,000Source | 20,248,000Source | 19,649,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 5,007,000Source | 7,423,000Source | 5,177,000Source | 5,369,000Source | 5,584,000Source | 6,752,000Source | 22,359,000Source | 27,040,000Source | 20,352,000Source | 27,656,000Source |
Offerings
Registration 333-294454
Filing attachments
tm2621105d1_ex4-1.htm · 8-K · 2026-07-22
EX-4.1 2 tm2621105d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 PRE-FUNDED COMMON STOCK PURCHASE WARRANT DARIOHEALTH CORP. Warrant Shares: Issue Date: _____________, 2026 ──────────────────────────────────────────────────────── THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any…
Read attachment ↗tm2621105d1_ex99-1.htm · 8-K · 2026-07-22
EX-99.1 6 tm2621105d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules The financing was led by continued support of existing long-term institutional investors along with participation from a new global fundamental institutional investor NEW YORK, July 22, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the “Company,” “DarioHealth” or “Dario”), a leading AI-powered heal…
Read attachment ↗tm2611605d1_ex99-1.htm · 8-K · 2026-04-13
EX-99.1 2 tm2611605d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial Scaling Mr. Palumbo’s deep relationships across health systems, payers and healthcare’s senior executive community expected to accelerate Dario’s commercial partnerships and position the Company to realize its full strategic value NEW YORK, April 13, 2026 - DarioHealth Corp. (NASDAQ: DRIO) (the “Company” or “Dario”),…
Read attachment ↗drio-20251231xex4d3.htm · 10-K · 2026-03-19
Exhibit 4.3 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of the securities of DarioHealth Corp. (the “Company”) is a summary only and pertains to the Company’s common stock and preferred stock, which are the Company’s only securities registered under Section 12 of the Securities Exchange Act of 1934, as amended. This summary is not complete and is subject to and qualified by the applicable provisio…
Read attachment ↗tm2530754d1_ex4-1.htm · 8-K · 2025-11-10
EX-4.1 2 tm2530754d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUED HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY OTHER SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT COVERING SUCH SECURITIES UNDER THE SECURITIES ACT AND ANY OTHER APPLICABLE SECURITIES LAWS, OR (2) AN EXEMPTION FROM REGISTRATION UNDE…
Read attachment ↗tm2526967d1_ex4-1.htm · 8-K · 2025-09-25
EX-4.1 3 tm2526967d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT…
Read attachment ↗